Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/64202
Type
ArticleCopyright
Open access
Collections
Metadata
Show full item record10
CITATIONS
10
Total citations
9
Recent citations
1.76
Field Citation Ratio
0.94
Relative Citation Ratio
DENGUE INFECTION IN CHILDREN IN FORTALEZA, BRAZIL: A 3-YEAR SCHOOL-BASED PROSPECTIVE COHORT STUDY
Author
Affilliation
Universidade Federal do Ceará. Fortaleza, CE, Brasil.
GlaxoSmithKline, Wavre, Belgium.
Secretaria de Saúde do Estado do Ceará. Hospital São José de Doenças Infecciosas. Fortaleza, CE, Brasil / Universidade de Fortaleza. Programa de Pós-Graduação em Ciências Médicas. Fortaleza, CE, Brasil.
Universidade Federal do Ceará. Fortaleza, CE, Brasil.
Laboratório Central de Saúde Publica do Ceará. Fortaleza, CE, Brasil.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
GSK, Rixensart, Belgium.
GlaxoSmithKline, Wavre, Belgium.
GlaxoSmithKline, Wavre, Belgium.
Secretaria de Saúde do Estado do Ceará. Hospital São José de Doenças Infecciosas. Fortaleza, CE, Brasil / Universidade de Fortaleza. Programa de Pós-Graduação em Ciências Médicas. Fortaleza, CE, Brasil.
Universidade Federal do Ceará. Fortaleza, CE, Brasil.
Laboratório Central de Saúde Publica do Ceará. Fortaleza, CE, Brasil.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
GSK, Rixensart, Belgium.
GlaxoSmithKline, Wavre, Belgium.
Abstract
Dengue is endemic in Brazil. The dengue surveillance system’s reliance on passive reporting may underestimate disease incidence and cannot detect asymptomatic/pauci-symptomatic cases. In this 3-year prospective cohort study (NCT01391819) in 5- to 13-year-old children from nine schools in Fortaleza (N = 2,117), we assessed dengue virus (DENV) infection seroprevalence by IgG indirect ELISA at yearly visits and disease incidence through active and enhanced passive surveillance. Real-time quantitative polymerase chain reaction (RT-qPCR) and DENV IgM/IgG capture ELISA were used for diagnosis. We further characterized confirmed and probable cases with a plaque reduction neutralization test. At enrollment, 54.1% (95% CI: 46.6, 61.4) of children were DENV IgG positive. The annual incidence of laboratory-confirmed symptomatic dengue cases was 11.0 (95% CI: 7.3, 14.7), 18.1 (10.4, 25.7), and 10.2 (0.7, 19.7), and of laboratory-confirmed or probable dengue cases with neutralizing antibody profile evocative of dengue exposure was 13.2 (6.6, 19.9), 18.7 (5.3, 32.2), and 8.4 (2.4, 19.2) per 1,000 child-years in 2012, 2013, and 2014, respectively. By RTqPCR, we identified 14 DENV-4 cases in 2012–2013 and seven DENV-1 cases in 2014. During the course of the study, 32.8% of dengue-naive children experienced a primary infection. Primary inapparent dengue infection was detected in 20.3% (95% CI: 13.6, 29.1) of dengue-naive children in 2012, 8.7% (6.9, 10.9) in 2013, and 5.1% (4.4, 6.0) in 2014. Our results confirmed the high dengue endemicity in Fortaleza, with active and enhanced passive surveillance detecting three to five times more cases than the National System of Disease Notification.
Share